EuroAsia RND — Research & DevelopmentRNDResearch & Development Enquiry 0

Bosutinib

BCR-ABL/SRC TKI (2nd-gen)

CAS
380843-75-4
Formula
C26H29Cl2N5O3
Mol. weight
530.45 g/mol
Purity
≥99%

Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.

2D structure of Bosutinib
Structure from PubChem CID 5328940

BCR-ABL + Src inhibitor. Bosutinib has unique GIST vs imatinib profile. GI side effects instead of QTc.

Target class: BCR-ABL and SRC inhibitors
Research areas: Leukemia

Related compounds

SMILESCN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC
InChIKeyUBPYILGKFZZVDX-UHFFFAOYSA-N